NICOLE DEYETTE: Open Payments
NPI 1598548760 · LATHAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 14 payments from 7 companies in 2025. Trend: 2023 $97 · 2024 $783 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $75 |
| Exeltis, USA Inc. | 3 | $71 |
| Astellas Pharma US Inc | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| SHIELD THERAPEUTICS INC | 1 | $33 |
| Novo Nordisk Inc | 1 | $22 |
Products named: SLYND, MYFEMBREE, Veozah, GARDASIL 9, ACCRUFER, GEMTESA, Lynkuet, Mirena.
Industry payments across NY — which companies pay providers there.
